Atrial pacing failure following termination of atrial fibrillation by acute administration of disopyramide phosphate

Journal of Interventional Cardiac Electrophysiology

Volumn 13, Issue 1, 2005, Pages 51-53

  Anzawa, Ryuko ^a   Ishikawa, Shin Ichiro ^a   Tanaka, Yasuyuki ^a   Okazaki, Fumiko ^a   Mochizuki, Seibu ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atrial fibrillation; Disopyramide phosphate; Pacemaker; Pacing threshold

Indexed keywords

DISOPYRAMIDE PHOSPHATE;

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CASE REPORT; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INFUSION; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART PALPITATION; HUMAN; PRIORITY JOURNAL; SICK SINUS SYNDROME; SINUS NODE; TREATMENT FAILURE;

AGED; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; COMBINED MODALITY THERAPY; DISOPYRAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; PACEMAKER, ARTIFICIAL; RISK ASSESSMENT; TREATMENT FAILURE;

EID: 20844449248     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10840-005-0647-9     Document Type: Article

References (10)

1. Hellenstrand KJ, Burnett PJ, Milne JR, Bexton RS, Nathan AW, Camm AJ. Effect of the antiarrhythmic agent flecainide acetate on acute and chronic pacing threshold. PACE 1983;6:892-899.
2. Antonelli D, Freedberg NA, Rosenfeld T. Acute loss of capture due to flecainide acetate. PACE 2001;24:1170.
3. Numata T, Abe H, Nagatomo T, Koshi K, Nakashima Y. Ventricular pacing failure after a single oral dose of pilsicainide in a patient with a permanent pacemaker and paroxysmal atrial fibrillation. PACE 2000;28:1436-1438.
4. Niarchos AP. Disopyramide: Serum level and arrhythmia conversion. Am Heart J 1976;92:57-64.
5. Nielsen JC, Bottcher M, Nielsen TT, Pedersen AK, Andersen HR. Regional myocardial blood flow in patients with sick sinus syndrome randomized to long-term single chamber atrial or dual chamber pacing - effect of pacing mode and rate. J Am Coll Cardiol 2000;35:1453-1461.
6. Hayler AM, Holf DW, Volans GN. Fatal overdose with disopyramide. Lancet 1978;1:968-970.
7. Soriano J, Almendral J, Arenal A, San Roman D, Delcan JL, Josephson ME. Rate-dependent failure of ventricular capture in patients treated with oral propafenone. Eur Heart J 1992;13:269-274.
8. Khan IA. Atrial stunning: Basics and clinical considerations. Int J Cardiol 2003;92:113-128.
9. Nakazato Y, Nakata Y, Hisaoka T, Sumiyoshi M, Ogura S, Yamaguchi H. Clinical and electrophysiological characteris of atrial standstill. PACE 1995;18:1244-1254.
10. Sanders P, Morton JB, Kistler PM, Vohra JK, Kaiman JM, Sparks PB. Reversal of atrial mechanical dysfunction after cardioversion of atrial fibrillation: Implications for the mechanisms of tachycardia- mediated atrial cardiomyopathy. Circulation 2003;108:1976-1984.